LAXMI ORGANIC INDUS LTD
LXCHEM · General/Diversified · NSE
₹141
Current Market Price
Fair Value (DCF)
₹62
Margin of Safety
-56.1%
Updated 2d ago
YieldIQ Score
23/100
Piotroski F-Score
4/9
Economic Moat
None
Confidence
44%
ROE
—
Debt/Equity
0.17
WACC
11.1%
Market Cap
₹3,905 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
9.1%
Return on capital employed
EV / EBITDA
17.6×
Enterprise multiple
Debt / EBITDA
1.1×
Leverage vs earnings
Interest Coverage
8.9×
EBIT covers interest
Current Ratio
1.34×
Short-term liquidity
Asset Turnover
0.98×
Revenue per ₹ of assets
Revenue CAGR (3Y)
-1.1%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹140.85
Bear case
₹40.51
MoS -247.7%
Base case
₹61.81
MoS -127.9%
Bull case
₹89.37
MoS -57.6%
Ratio Trends
LXCHEM · last 5 annual periods
ROE
6.0%
ROCE
14.1%
Operating Margin
—
Debt / Equity
0.14×
PE
238.0×
EV / EBITDA
24.7×
Historical Financials
LXCHEM · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹1606 Cr | ₹3084 Cr | ₹712 Cr | ₹792 Cr | ₹2977 Cr | +16.7% |
| EBITDA | — | ₹380 Cr | ₹256 Cr | ₹284 Cr | ₹305 Cr | -5.4% |
| EBIT | ₹167 Cr | ₹333 Cr | ₹51.2 Cr | ₹67.4 Cr | — | -20.3% |
| PAT | ₹123 Cr | ₹256 Cr | ₹25.9 Cr | ₹44.3 Cr | ₹114 Cr | -1.9% |
| EPS (diluted) | ₹5.38 | ₹9.59 | ₹0.97 | ₹1.63 | — | -25.8% |
| CFO | ₹122 Cr | ₹45.7 Cr | ₹161 Cr | ₹562 Cr | ₹108 Cr | -3.0% |
| CapEx | — | — | — | — | ₹-394 Cr | — |
| FCF | — | — | — | — | ₹-286 Cr | — |
| Total Assets | — | ₹2249 Cr | ₹2329 Cr | ₹2827 Cr | ₹3045 Cr | +7.9% |
| Total Debt | — | — | ₹237 Cr | ₹38.5 Cr | ₹258 Cr | +2.1% |
| Shareholders' Equity | — | — | ₹1420 Cr | ₹1798 Cr | ₹1907 Cr | +7.7% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
LXCHEM vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| VISHNU VISHNU | — | — | Pending | 13.7% | — |
| NEOGEN NEOGEN | — | — | Pending | 4.4% | — |
| INDIGOPNTS INDIGOPNTS | — | — | Pending | 13.8% | — |
| RESPONIND RESPONIND | — | — | Pending | 14.8% | — |
| POCL POCL | — | — | Pending | 9.8% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for LXCHEM in the last 10 years.
AI Analysis Summary
Laxmi Organic Indus appears overvalued by 56.1%, with a standout strength in its interest coverage of 8.9x, but a concern is its negative 3-year revenue CAGR of -1.1%.
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of LXCHEM →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for LXCHEM →
Compare
Head-to-head with peers
Compare LXCHEM side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse LXCHEMNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.